Gorberg, Victoria
Borisov, Veronika
Greig, Iain R.
Pertwee, Roger G.
McCaffery, Peter
Anavi-Goffer, Sharon http://orcid.org/0000-0002-3364-5134
Funding for this research was provided by:
Tourette Association of America (Research Grant Award)
University of Aberdeen (The Elphinstone Scholarship for Ph.D. students)
Article History
Received: 19 November 2021
Accepted: 17 May 2022
First Online: 6 June 2022
Declarations
:
: All experiments were approved by the Institutional Animal Use and Care Committees of Tel-Aviv University and Ariel University and were in accordance with the UK Home Office, EU directive 63/2010E, and the Animal (Scientific Procedures) Act 1986.
: Not applicable.
: Not applicable.
: SAG is a member of the Clinical Advisory Committee for Tourette syndrome, Tourette Syndrome Association of Israel (TSAI), and a member of the International Consortium For Medical Cannabis and Related Drugs For Tic Disorders, Tourette Association of America (TAA). SAG is Section Editor for the Endocannabinoid system of the Journal of Cannabis Research and is the founder of Fride Pharma. RGP is a member of the Board of Directors of the International Cannabinoid Research Society and of the International Association for Cannabinoid Medicines. RGP receives royalties for his published books “Handbook of Cannabis” and “Endocannabinoids.” SAG, IG, and RGP have filed patent applications related to cannabinoids. The authors VG, VB, and PM have no financial/non-financial interests.